Sign in Subscribe
Arthritis

COVID-19 Vaccination May Induce Sustained Remission in Rheumatoid Arthritis

Strategic Insights

— 1 min read

New research on the effects of COVID-19 vaccination on autoimmune diseases such as rheumatoid arthritis has been reported by medical professionals at Madonna delle Grazie Hospital in Matera, Italy. A 79-year-old woman with a 40-year history of rheumatoid arthritis, who received three doses of the Pfizer vaccine, experienced a significant reduction in symptoms and sustained remission after discontinuing conventional treatment. This case suggests that COVID-19 vaccination may induce an immunologic "reset" that contributes to sustained remission in patients with rheumatoid arthritis.

Key Takeaways:

  • A 79-year-old woman with a 40-year history of rheumatoid arthritis experienced sustained remission after receiving three doses of the Pfizer vaccine.
  • The patient discontinued leflunomide due to concerns about infection risk and instead showed a significant reduction in symptoms and sustained remission.
  • Clinical and radiographic assessments confirmed inactive rheumatoid arthritis, with residual joint damage in the hands.
  • Radiographs demonstrated stable erosions and osteopenic changes, corticosteroid therapy was progressively reduced, and anti-citrullinated protein antibody (ACPA) titers declined by approximately 50%.
  • Further research is warranted to explore the potential benefits of COVID-19 vaccination in RA management.

Statistics:

  • 40 years: duration of rheumatoid arthritis in the patient.
  • 79: age of the patient.
  • 20 mg/day: dosage of leflunomide prescribed to the patient.
  • 8 mg/day: dosage of corticosteroids (Urbason) prescribed to the patient.
  • 50%: reduction in anti-citrullinated protein antibody (ACPA) titers compared to pre-vaccination levels.
  • 3-year follow-up: duration of sustained remission observed in the patient's case.

Sources:

  • Sustained remission of rheumatoid arthritis following COVID-19 vaccination. Central European Journal of Immunology, 2025;50(2):188-189.
  • NewsRx. Findings from Madonna delle Grazie Hospital in the Area of COVID-19 Reported (Sustained remission of rheumatoid arthritis following COVID-19 vaccination). Medical Letter on the CDC & FDA. November 2, 2025; p 43.

Read more